A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Thermo Fisher Scientific Shows Improved Relative Price Performance; Still Shy Of Benchmark - Investor's Business Daily
Thermo Fisher Scientific Shows Improved Relative Price Performance; Still Shy Of Benchmark Investor's Business Daily
Thermo Fisher Expands Biopharma Offerings With $9B Deal for Clinical Trial Software Firm Clario - MedCity News
Thermo Fisher Expands Biopharma Offerings With $9B Deal for Clinical Trial Software Firm Clario MedCity News
Investors in Thermo Fisher Scientific (NYSE:TMO) have seen returns of 15% over the past three years - Yahoo Finance
Investors in Thermo Fisher Scientific (NYSE:TMO) have seen returns of 15% over the past three years Yahoo Finance
Thermo Fisher Scientific to Acquire Clario to Provide Deeper Clinical Insights - MedTech Intelligence
Thermo Fisher Scientific to Acquire Clario to Provide Deeper Clinical Insights MedTech Intelligence
Thermo Fisher adds clinical trial tech outfit Clario to goodie bag in $9B deal - Fierce Biotech
Thermo Fisher adds clinical trial tech outfit Clario to goodie bag in $9B deal Fierce Biotech
Thermo Fisher to buy Clario for $8.8bn - Clinical Trials Arena
Thermo Fisher to buy Clario for $8.8bn Clinical Trials Arena
Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion - Reuters
Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion Reuters
Thermo Fisher Scientific to accelerate life science breakthroughs with OpenAI - SelectScience
Thermo Fisher Scientific to accelerate life science breakthroughs with OpenAI SelectScience
Thermo Fisher to acquire clinical trial data firm Clario for $8.9B - MedTech Dive
Thermo Fisher to acquire clinical trial data firm Clario for $8.9B MedTech Dive
Latham & Watkins Advises Clario in US$8.875 Billion Sale to Thermo Fisher Scientific - Latham & Watkins LLP
Latham & Watkins Advises Clario in US$8.875 Billion Sale to Thermo Fisher Scientific Latham & Watkins LLP
Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights - Business Wire
Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights Business Wire